Stock comparison
IDEXX Laboratories
Inspire Medical Systems
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
INSP
Inspire Medical Systems
Market cap
$1.26B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | INSP | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 50D | IDXX |
| Benjamin Graham | 80A | 37D | IDXX |
| Philip Fisher | 75B | 48D | IDXX |
| Peter Lynch | 71B | 71B | Tie |
| Joel Greenblatt | 83C | 49D | IDXX |
| Charlie Munger | 87A | 32F | IDXX |
| Terry Smith | 84A | 33F | IDXX |
Side-by-side metrics
| Metric | IDXX | INSP |
|---|---|---|
| Market cap | $44.12B | $1.26B |
| P/E (TTM) | 39.0x | 9.2x |
| EV/EBIT | 31.6x | 22.3x |
| ROIC (TTM) | 40.66% | 6.24% |
| Gross margin | 62.05% | 85.78% |
| Net margin | 24.63% | 14.33% |
| Revenue CAGR 5y | 7.56% | 40.6% |
| EPS CAGR 5y | 10.79% | - |
| Debt / Equity | 0.7x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$44.12Bvs $1.26B+97%
- ROIC (TTM)40.66%vs 6.24%+85%
- Net margin24.63%vs 14.33%+42%
INSP leads on
- Debt / Equity0.0xvs 0.7x+95%
- Revenue CAGR 5y40.6%vs 7.56%+81%
- P/E (TTM)9.2xvs 39.0x+77%
- EV/EBIT22.3xvs 31.6x+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.